Delivery Order SPE2DR25D3103-SPE2DR26F0F9A
Award Date 3/9/26
Potential Completion Date 3/10/26
Potential Value $2.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency issued a $3,598.88 delivery order to Amerisourcebergen Drug Corp on March 6, 2026, for Journavx 50 mg tablets (30-count units), with ultimate completion on March 9, 2026.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Pricing is firm fixed price with no set-aside applied.</p>
- The Defense Logistics Agency awarded a delivery order valued at $4,706.84 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Journavx 50 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 7, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's broader pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,630.82 to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Journavx 50 mg tablets in unit dose packaging of 100 units. The order will be completed by February 2, 2026, and will be performed at the contractor's location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Journavx 50 mg tablets in unit dose packaging (100 count). This is a firm fixed-price delivery order with a ceiling value of $3,305.43, with an ultimate completion date of July 1, 2025. The award utilizes no set-aside designation and represents a competitively awarded contract. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $12,518.12 to AmerisourceBergen Drug Corp for Journavx 50 mg tablets (30-count packaging) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a $2,248.02 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Journavx 50 mg on December 17, 2025, with completion scheduled for December 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,808.88 to AmerisourceBergen Drug Corp for the supply of Journavx 50 mg tablets (30-count) under a firm fixed price contract type. The award was made on November 21, 2025, with an ultimate completion date of November 24, 2025. This non-competitive delivery order represents a discrete purchase of pharmaceutical inventory to support federal medical supply requirements. Performance will be executed from AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $6,943.92 to AmerisourceBergen Drug Corp for the supply of JOURNAVX 50 MG tablets (30-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- This delivery order, awarded to AmerisourceBergen Drug Corp on November 12, 2025, provides for the supply of Journavx 50 mg tablets (30-count units) with a ceiling value of $14,471.04 under firm fixed-price terms. The award is not set-aside and represents a competitive procurement by the Defense Logistics Agency, a component of the Department of Defense responsible for managing the supply chain for military and federal healthcare systems. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,020.90 to Amerisourcebergen Drug Corp (subsidiary of Cencora, Inc.) on January 8, 2026, for the supply of Journavx 50 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 9, 2026. The work will be performed at Amerisourcebergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F0F9ADelivery Order
The Defense Logistics Agency issued a $2,629.50 delivery order to Amerisourcebergen Drug Corp on March 9, 2026, for 30-count tablets of Journavx 50 mg, with an ultimate completion date of March 10, 2026. Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied. The source does not identify the parent IDV by name; however, Amerisourcebergen Drug Corp holds a significant DLA Troop Support Medical IDC valued at $999,999,999.00 through December 2026 that serves as a global pharmaceutical supply vehicle supporting military healthcare programs.
Generated 6/7/26, 10:01 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 3/8/26 |